Company: LASE
Filing Date: 2025-12-23
Form Type: 10-Q
Source: 0001493152-25-028857
Chunk: 27

Company: Laser Photonics Corp
Filing Date: 2025-12-23
Form: 10-Q
Item: Part I, Item 1
Chunk 27
---
 3.2 million unrestricted shares of the Company’s common stock. The Company also has agreed, subject to customary
exceptions, for a period of 30 days starting on September 3, 2025, not to issue any shares of its common stock nor to file any registration
statant or any amendment or supplement to any existing registration statement. The excess of the FV of the shares of common stock over
the FV recalculated using Black-Scholes method at the date of the operation was considered and accounted as deemed dividend.

On
September 22, 2025, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited
investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement
(the “Offering”) (i) 1,098,902
shares (the “Shares”) of common stock of the Company,
$0.001
par value (the “Common Stock”), (ii) series A warrants
to purchase up to 1,098,902
shares of Common Stock (the “Series A Warrants”)
and (iii) series B warrants to purchase up to 1,098,902
shares of Common Stock (the “Series B Warrants”
and, with the Series A Warrants, the “Common Warrants” and, collectively with the Shares, and the Series B Warrants, the
“Securities”) for a purchase price of $3.64
per share of Common Stock and related Common Warrants, for
a net total of $3,487,353, the fees were net against the proceeds. The Offering was closed on September 29, 2025, subjected to
customary closing conditions. The Company also issued to the placement agent facilitating the Exchange Agreement or its designees warrants
to purchase an aggregate of 76,923
shares of its restricted common stock that are exercisable
for five
years at $4.55
per share subject to customary adjustments, including for stock
splits, stock dividends, rights offerings and fundamental transactions such as a merger resulting in a change of control.

The
Series A Warrants have an exercise price of $3.40 per share, are exercisable upon issuance (the “Initial Exercise Date”),
and expire five years following the effective date of the registration statement to be filed in connection with the Offering. The Series
B Warrants have an exercise price of 3.